The Urgent Need: Regenerating antibacterial drug discovery development - Report of the British Society for Antimicrobial Chemotherapy Initiative

The British Society for Antimicrobial Chemotherapy is gravely concerned that the relentless rise in antibiotic resistance, occurring at a time when pharmaceutical companies are disinvesting in the discovery and development of antibacterial agents, will have severe and harmful effects on global health and the ability to treat infections in hospitals and the community. The antibiotic pipeline is almost empty, yet the need for new antibiotics to treat the increasing number of drug resistant infections continues to rise The reports of the three expert evidence days – research, regulatory and economics – each detail options for consideration and action. The recommendations take the form of a proposed agenda for action, comprising a number of legacy activities that will encompass some or all of these options